Photo taken from cancer.gov
Jun 29, 2024, 12:06
Injectable form of nivolumab vs the intravenous form against kidney cancer – NCI
National Cancer Institute (NCI) shared on X:
“In a Clinical Trial, an injectable form of nivolumab (Opdivo) was as effective against kidney cancer as the intravenous form of the drug. Side effects were also similar, and treatment time was shorter.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 9, 2025, 14:01
May 9, 2025, 13:49